[
  {
    "ts": null,
    "headline": "Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment",
    "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how pharmaceuticals stocks fared in Q4, starting with Elanco (NYSE:ELAN).",
    "url": "https://finnhub.io/api/news?id=6ebeca7ae27a4266f203e5748303d94f9e9622104bc9217b2c514eea493340fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742288480,
      "headline": "Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment",
      "id": 133317323,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how pharmaceuticals stocks fared in Q4, starting with Elanco (NYSE:ELAN).",
      "url": "https://finnhub.io/api/news?id=6ebeca7ae27a4266f203e5748303d94f9e9622104bc9217b2c514eea493340fa"
    }
  }
]